Insulet
Stock Forecast, Prediction & Price Target
Insulet (PODD) stock Price Target by analysts
$278.75
Potential downside: -14.95%
Insulet price prediction
What is Insulet stock analysts` prediction?
Insulet stock forecast: Based on 4 Wall Street analysts` predicted price targets for Insulet in the last 3 months, the avarage price target is $278.75, with a high forecast of $NaN. The average price target represents a -14.95% change from the last price of $327.75.
Disclaimer: This is not investment advice. Don't use price targets as the only investment indicator. Always remember to do your own thorough research and due diligence before making an investment decision.
Insulet stock Price Target by analysts
Full breakdown of analysts given Insulet price targets
| Analyst name & company | Analyst win rate | Publish date | Price target | Price when posted | Source | Historical targets |
|---|---|---|---|---|---|---|
Marie Thibault BTIG | 0% 0/2 | 10 months ago | $270 -17.62% downside | $268.96 | StreetInsider | Previous targets (1) |
Lee Hambright Bernstein | 0% 0/1 | 10 months ago | $300 -8.46% downside | $241.32 | StreetInsider | Previous targets (0) |
Jayson Bedford Raymond James | 50% 1/2 | 11 months ago | $260 -20.67% downside | $231.61 | TheFly | Previous targets (1) |
Matt O'Brien Piper Sandler | 0% 0/3 | 12 months ago | $285 -13.04% downside | $233.89 | TheFly | Previous targets (2) |
Steven Lichtman Oppenheimer | 50% 1/2 | about 1 year ago | $233 -28.90% downside | $193.54 | StreetInsider | Previous targets (1) |
Matt O'Brien Piper Sandler | 0% 0/3 | about 1 year ago | $230 -29.82% downside | $193.52 | StreetInsider | Previous targets (2) |
Matthew Taylor Jefferies | 0% 0/1 | about 1 year ago | $260 -20.67% downside | $193.54 | StreetInsider | Previous targets (0) |
Marie Thibault BTIG | 0% 0/2 | about 1 year ago | $250 -23.72% downside | $199.79 | TheFly | Previous targets (1) |
Matt Miksic Barclays | 0% 0/1 | over 1 year ago | $200 -38.97% downside | $165.9 | TheFly | Previous targets (0) |
Mike Polark Wolfe Research | 0% 0/1 | over 1 year ago | $200 -38.97% downside | $176.4 | TheFly | Previous targets (0) |
Kyle Rose Canaccord Genuity | 50% 1/2 | over 1 year ago | $226 -31.04% downside | $166.64 | StreetInsider | Previous targets (1) |
Unknown Morgan Stanley | N/A | over 2 years ago | $320 -2.36% downside | $295 | Benzinga | N/A |
Matt O'Brien Piper Sandler | 0% 0/3 | almost 3 years ago | $340 3.73% upside | $255.35 | TheFly | Previous targets (2) |
Cecilia Furlong Morgan Stanley | 100% 1/1 | almost 3 years ago | $273 -16.70% downside | $224.16 | TheFly | Previous targets (0) |
Jayson Bedford Raymond James | 50% 1/2 | about 3 years ago | $280 -14.56% downside | $260.03 | Pulse 2.0 | Previous targets (1) |
Travis Steed Bank of America Securities | 100% 1/1 | over 3 years ago | $300 -8.46% downside | $265.39 | Pulse 2.0 | Previous targets (0) |
Matthew Taylor UBS | 100% 1/1 | over 3 years ago | $325 -0.83% downside | $253.19 | TheFly | Previous targets (0) |
Steven Lichtman Oppenheimer | 50% 1/2 | over 3 years ago | $275 -16.09% downside | $248 | TheFly | Previous targets (1) |
Kyle Rose Canaccord Genuity | 50% 1/2 | over 3 years ago | $330 0.68% upside | $259.14 | TheFly | Previous targets (1) |
Ravi Misra Berenberg Bank | 100% 1/1 | almost 4 years ago | $295 -9.99% downside | $313.47 | TipRanks Contributor | Previous targets (0) |
Joanne Wuensch Citigroup | 0% 0/1 | almost 4 years ago | $350 6.78% upside | $308 | TheFly | Previous targets (0) |
Raj Denhoy Jefferies | 0% 0/1 | almost 4 years ago | $340 3.73% upside | $297.51 | StreetInsider | Previous targets (0) |
Josh Jennings Cowen & Co. | 100% 1/1 | about 4 years ago | $310 -5.41% downside | $271.48 | StreetInsider | Previous targets (0) |
JP McKim Thrivent | 100% 1/1 | over 4 years ago | $250 -23.72% downside | $234.19 | StreetInsider | Previous targets (0) |
Insulet Financial Estimates
Insulet Revenue Estimates
Insulet EBITDA Estimates
Insulet Earnings per Share Estimates
| Passed | Analyst forecast | ||||||
|---|---|---|---|---|---|---|---|
| Metric | 12/31/2021 | 12/31/2022 | 12/31/2023 | 12/31/2025 | 12/31/2026 | 12/31/2027 | 12/31/2028 |
Revenue
% change YoY
| $1.09B N/A | $1.30B 18.79% | $1.69B 30.01% | Avg: $2.34B Low: $2.27B High: $2.40B avg. 38.06% | Avg: $2.74B Low: $2.68B High: $2.79B avg. 16.95% | Avg: $3.16B Low: $3.09B High: $3.22B avg. 15.45% | Avg: $3.49B Low: $3.41B High: $3.56B avg. 10.33% |
Net Income
% change YoY
| $16.8M N/A | $4.6M -72.61% | $206.3M 4384.78% | Avg: $282.45M Low: $240.04M High: $336.50M avg. 36.91% | Avg: $357.65M Low: $279.80M High: $401.29M avg. 26.62% | Avg: $434.04M Low: $421.69M High: $445.66M avg. 21.35% | Avg: $544.88M Low: $529.37M High: $559.46M avg. 25.53% |
EBITDA
% change YoY
| $124.1M N/A | $36.5M -70.58% | $323.6M 786.57% | Avg: $186.91M Low: $181.37M High: $191.66M avg. -42.23% | Avg: $218.61M Low: $213.82M High: $223.11M avg. 16.95% | Avg: $252.38M Low: $246.86M High: $257.58M avg. 15.45% | Avg: $278.46M Low: $272.36M High: $284.19M avg. 10.33% |
EPS
% change YoY
| $0.25 N/A | $0.07 -73.48% | $2.96 4364.55% | Avg: $3.78 Low: $3.26 High: $4.57 avg. 27.58% | Avg: $4.8 Low: $3.8 High: $5.45 avg. 26.98% | Avg: $5.89 Low: $5.73 High: $6.05 avg. 22.92% | Avg: $7.4 Low: $7.19 High: $7.6 avg. 25.53% |
Operating Expenses
% change YoY
| $626.1M N/A | $768M 22.66% | $939.9M 22.38% | Avg: $1.00B Low: $972.75M High: $1.02B avg. 6.65% | Avg: $1.17B Low: $1.14B High: $1.19B avg. 16.95% | Avg: $1.35B Low: $1.32B High: $1.38B avg. 15.45% | Avg: $1.49B Low: $1.46B High: $1.52B avg. 10.33% |
FAQ
What is Insulet stock earnings growth forecast?
Wall Street analysts estimate the annual average earnings growth rate of 27.60% in 2025-2028.
We have gathered data from 15 analysts. Their low estimate is 240.04M, average is 282.45M and high is 336.50M.
What is Insulet stock revenue growth forecast?
Wall Street analysts forecast annual average revenue growth of 20.20% in 2025-2028.
We have gathered data from 17 analysts. Their low revenue estimate is $2.27B, average is $2.34B and high is $2.40B.
What is Insulet stock earnings per share growth forecast?
Wall Street analysts forecast annual average earnings growth of 25.75% in 2025-2028.
We have gathered data from 15 analysts. Their low earnings per share estimate is $3.26, average is $3.78 and high is $4.57.
What is the best performing analyst?
In the last twelve months 4 analysts have been covering Insulet stock. The most successful analyst is Marie Thibault.